申请人:Player R. Mark
公开号:US20050131022A1
公开(公告)日:2005-06-16
The invention is directed to compounds of Formulae I:
wherein A, R
1
, R
2
, R
3
, R
4
, X, and W are set forth in the specification, as well as solvates, hydrates, tautomers or pharmaceutically acceptable salts thereof, that inhibit protein tyrosine kinases, especially c-fms kinase.
该发明涉及以下式I的化合物:其中A、R1、R2、R3、R4、X和W如规范中所述,以及其溶剂合物、水合物、互变体或药学上可接受的盐,可以抑制蛋白酪氨酸激酶,尤其是c-fms激酶。